<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/13307" />
  <subtitle />
  <id>http://localhost:80/xmlui/handle/123456789/13307</id>
  <updated>2026-04-24T18:18:13Z</updated>
  <dc:date>2026-04-24T18:18:13Z</dc:date>
  <entry>
    <title>Nanobiotechnology: Cradle for revolution in drug carrier systems</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/13441" />
    <author>
      <name>Zafar, Saba</name>
    </author>
    <author>
      <name>Rasul, Akhtar</name>
    </author>
    <author>
      <name>Iqbal, Muhammad Shahid</name>
    </author>
    <author>
      <name>Rasool, Maria</name>
    </author>
    <author>
      <name>Ahmed, Bilal</name>
    </author>
    <author>
      <name>Qadir, Muhammad Imran</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/13441</id>
    <updated>2022-10-20T10:00:06Z</updated>
    <published>2021-01-16T00:00:00Z</published>
    <summary type="text">Title: Nanobiotechnology: Cradle for revolution in drug carrier systems
Authors: Zafar, Saba; Rasul, Akhtar; Iqbal, Muhammad Shahid; Rasool, Maria; Ahmed, Bilal; Qadir, Muhammad Imran
Abstract: : The role of nanobiotechnology in the treatment of diseases is limitless. In this review we tried to focus main&#xD;
aspects of nanotechnology in drug carrier systems for treatment and diagnosis of various diseases such as cancer,&#xD;
pulmonary diseases, infectious diseases, vaccine development, diabetes mellitus and the role of nanotechnology on our&#xD;
economy and its positive social impacts on our community. We discussed here about the different “Biotechnano&#xD;
Strategies” to develop new avenues and ultimately improve the treatment of multiple diseases.</summary>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Role of Kisspeptin-GPR54 system in regulation of reproductive functions in human and other mammals</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/13440" />
    <author>
      <name>Ilahi, Ikram</name>
    </author>
    <author>
      <name>Taqweem Ul Haq</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/13440</id>
    <updated>2022-10-20T09:59:43Z</updated>
    <published>2021-01-16T00:00:00Z</published>
    <summary type="text">Title: Role of Kisspeptin-GPR54 system in regulation of reproductive functions in human and other mammals
Authors: Ilahi, Ikram; Taqweem Ul Haq
Abstract: Kisspeptin is a 54- amino acid peptide that acts as a ligand of a receptor called GPR54 which is basically a&#xD;
transmembrane receptor that spins seven times across the cell membrane and coupled with G-protein. Kisspeptin&#xD;
regulates the development of reproductive functions and the onset of puberty in human and other mammals by acting at&#xD;
the brain, hypothalamus, pituitary and gonad levels of reproductive axis. Kisspeptin is also involved in regulation of&#xD;
trophoblastic invasion during pregnancy, ovulation, and sperm hyperactivation. Inactivating mutations in human&#xD;
kisspeptin gene (KISS1) cause idiopathic hypogonadotropic hypogonadism. Some mutations in human kisspeptin&#xD;
receptor gene (KISS1R) make the receptor inactive which result in idiopathic hypogonadotropic hypogonadism. Some&#xD;
mutations in human KISS1R gene make the receptor prematurely activated and result in the development of central&#xD;
precocious puberty. Central precocious puberty is also caused by some mutations in human KISS1 gene that make the&#xD;
kisspeptin resistant to degradation. This leads to an increased basal kisspeptin level and subsequently the development of&#xD;
central precocious puberty. Higher kisspeptin level has been detected in the serum and plasma of central precocious&#xD;
puberty patients, which suggest that serum or plasma kisspeptin level can be used as a marker for diagnosis of central&#xD;
precocious puberty.</summary>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>IR study of degradation of acetaminophen by iron nano-structured catalyst</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/13439" />
    <author>
      <name>Altaf, Iqbal</name>
    </author>
    <author>
      <name>Azmat, Rafia</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/13439</id>
    <updated>2022-10-20T09:59:03Z</updated>
    <published>2021-01-16T00:00:00Z</published>
    <summary type="text">Title: IR study of degradation of acetaminophen by iron nano-structured catalyst
Authors: Altaf, Iqbal; Azmat, Rafia
Abstract: Full degradation of acetaminophen (paracetamol) in aqueous solution was investigated at room temperature&#xD;
through heterogeneous iron nano-structured as catalyst in this article. Iron Nano-structured was prepared through simple&#xD;
hydrothermal processes using Iron oxide (Fe2O3) as precursor. The catalytic activity of as prepared Nano-catalyst (NC)&#xD;
was investigated in the degradation of the acetaminophen as an environmental pollutant, commonly called paracetamol,&#xD;
under different operating parameters like pH, dosages of acetaminophen and dose of NC. Remarkable differences in IR&#xD;
spectra were observed after reaction which showed complete degradation of 15 ppm of Acetaminophen using 0.1 g of&#xD;
nano-structured with the recovery of NC followed by its activity four times with full catalytic performance</summary>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Salicylic acid attenuates gentamicin-induced nephrotoxicity in rabbits</title>
    <link rel="alternate" href="http://localhost:80/xmlui/handle/123456789/13437" />
    <author>
      <name>Zaidi, Syeda Nuzhat Fatimah</name>
    </author>
    <author>
      <name>Usman, Sheikh Muhammad</name>
    </author>
    <id>http://localhost:80/xmlui/handle/123456789/13437</id>
    <updated>2022-10-20T09:58:14Z</updated>
    <published>2021-01-16T00:00:00Z</published>
    <summary type="text">Title: Salicylic acid attenuates gentamicin-induced nephrotoxicity in rabbits
Authors: Zaidi, Syeda Nuzhat Fatimah; Usman, Sheikh Muhammad
Abstract: Gentamicin (GM) is a generally utilized as an antibiotic against dangerous and life threatening&#xD;
contaminations, yet its value is restricted by the development of nephrotoxicity. The present investigation was intended&#xD;
to decide the defensive impact of salicylic acid (SA) in gentamicin-induced nephrotoxicity in rabbits. Quantitative&#xD;
assessment of gentamicin-induced structural changes and level of functional modifications in the kidneys were&#xD;
performed by biochemical examinations keeping in mind the end goal is to decide the potential protective impacts of SA&#xD;
co-administration with gentamicin. Gentamicin was seen to cause a serious nephrotoxicity which was proved by a&#xD;
plasma urea, plasmacreatinine, plasma uric acid, plasma Na+&#xD;
, plasma K+&#xD;
, intra-erythrocyte Na+&#xD;
 and intra-erythrocyte K+&#xD;
levels. On the other hand, simultaneous SA administration protected kidney tissue against the oxidative damage and the&#xD;
nephrotoxic effect caused by GM treatment. The outcomes from our investigation show that SA supplement lessens&#xD;
oxidative-stress related to renal damage by reducing oxygen free radicals in gentamicin-treated rabbits.</summary>
    <dc:date>2021-01-16T00:00:00Z</dc:date>
  </entry>
</feed>

